Preparation of multifunctional mesoporous SiO2 nanoparticles and anti-tumor action. (29th January 2023)

• Record Type: Journal Article
• Authors: Wu, Yijun; Sun, Zhiqiang; Song, Jinfeng; Mo, Liufang; Wang, Xiaochen; Liu, Hanhan; Ma, Yunfeng
• Is Part Of: Nanotechnology. Volume 34:Number 5(2023)
• Publication Date: 2023-01-29
• Subjects: preparations -- multifunctional -- mesoporous -- SiO2 -- nanoparticles -- antitumor; Nanotechnology -- Periodicals; Nanotechnology -- Periodicals; Nanotechnology; Publications périodiques; Nanotechnologies; Periodicals; 620.5
• DOI: 10.1088/1361-6528/ac9e5f
• Languages: English
• ISSNs: 0957-4484

Abstract

Abstract: A targeted drug delivery system was developed to accumulate specific drugs around tumor cells based on the redox, temperature, and enzyme synergistic responses of mesoporous silica nanoparticles. Mesoporous silica nanoparticles (MSN-NH2) and Doxorubicin (DOX) for tumor therapy were prepared and loaded into the pores of MSN- NH2 to obtain DOX@MSN(DM NPs). Hyaluronic acid (HA) was used as the backbone and disulfide bond was used as the linker arm to graft carboxylated poly (N-isopropylacrylamide)(PNIPAAm-COOH) to synthesize the macromolecular copolymer (HA-SS-PNIPAAm), which was modified to DM NPs with capped ends to obtain the nano-delivery system DOX@MSN@HA-SS-PNIPAAm(DMHSP NPs), and a control formulation was prepared in a similar way. DMHSP NPs specifically entered tumor cells via CD44 receptor-mediated endocytosis; the high GSH concentration (10 mM) of cells severed the disulfide bonds, the hyaluronidase sheared the capped HA to open the pores, and increased tumor microenvironment temperature due to immune response can trigger the release of encapsulated drugs in thermosensitive materials. In vitro and in vivo antitumor and hemolysis assays showed that DMHSP NPs can accurately target hepatocellular carcinoma cells with a good safety profile and have synergistic effects, which meant DMHSP NPs had great potential for tumor therapy.